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Detection of porcine reproductive and respiratory syndrome virus
(PRRSV)-specific IgM-IgA in oral fluid samples reveals PRRSV infection
in the presence of maternal antibody
Abstract
The ontogeny of PRRSV antibody in oral fluids has been described using isotype-specific ELISAs. Mirroring
the serum response, IgM appears in oral fluid by 7 days post inoculation (DPI), IgA after 7 DPI, and IgG by 9
to 10 DPI. Commercial PRRSV ELISAs target the detection of IgG because the higher concentration of IgG
relative to other isotypes provides the best diagnostic discrimination. Oral fluids are increasingly used for
PRRSV surveillance in commercial herds, but in younger pigs, a positive ELISA result may be due either to
maternal antibody or to antibody produced by the pigs in response to infection. To address this issue, a
combined IgM-IgA PRRSV oral fluid ELISA was developed and evaluated for its capacity to detect pig-
derived PRRSV antibody in the presence of maternal antibody. Two longitudinal studies were conducted. In
Study 1 (modified-live PRRS vaccinated pigs), testing of individual pig oral fluid samples by isotype-specific
ELISAs demonstrated that the combined IgM-IgA PRRSV ELISA provided better discrimination than
individual IgM or IgA ELISAs. In Study 2 (field data), testing of pen-based oral fluid samples confirmed the
findings in Study 1 and established that the IgM-IgA ELISA was able to detect antibody produced by pigs in
response to wild-type PRRSV infection, despite the presence of maternal IgG. Overall, the combined PRRSV
IgM-IgA oral fluid ELISA described in this study is a potential tool for PRRSV surveillance, particularly in
populations of growing pigs originating from PRRSV-positive or vaccinated breeding herds.
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A B S T R A C T
The ontogeny of PRRSV antibody in oral ﬂuids has been described using isotype-speciﬁc ELISAs. Mirroring the
serum response, IgM appears in oral ﬂuid by 7 days post inoculation (DPI), IgA after 7 DPI, and IgG by 9 to 10
DPI. Commercial PRRSV ELISAs target the detection of IgG because the higher concentration of IgG relative to
other isotypes provides the best diagnostic discrimination. Oral ﬂuids are increasingly used for PRRSV sur-
veillance in commercial herds, but in younger pigs, a positive ELISA result may be due either to maternal
antibody or to antibody produced by the pigs in response to infection. To address this issue, a combined IgM-IgA
PRRSV oral ﬂuid ELISA was developed and evaluated for its capacity to detect pig-derived PRRSV antibody in
the presence of maternal antibody. Two longitudinal studies were conducted. In Study 1 (modiﬁed-live PRRS
vaccinated pigs), testing of individual pig oral ﬂuid samples by isotype-speciﬁc ELISAs demonstrated that the
combined IgM-IgA PRRSV ELISA provided better discrimination than individual IgM or IgA ELISAs. In Study 2
(ﬁeld data), testing of pen-based oral ﬂuid samples conﬁrmed the ﬁndings in Study 1 and established that the
IgM-IgA ELISA was able to detect antibody produced by pigs in response to wild-type PRRSV infection, despite
the presence of maternal IgG. Overall, the combined PRRSV IgM-IgA oral ﬂuid ELISA described in this study is a
potential tool for PRRSV surveillance, particularly in populations of growing pigs originating from PRRSV-
positive or vaccinated breeding herds.
1. Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV) was
ﬁrst identiﬁed in 1991 (Wensvoort et al., 1991). Assays for the detec-
tion of PRRSV serum antibody became widely available shortly there-
after, including immunoperoxidase monolayer (Wensvoort et al.,
1992), immunoﬂuorescence (Benﬁeld et al., 1992), serum-virus neu-
tralization (Benﬁeld et al., 1992), and ELISA (Albina et al., 1992). The
detection of PRRSV serum antibody using ﬂuorescent microsphere-
based assays has been reported under experimental conditions
(Langenhorst et al., 2012). At the present time, the ELISA is the most
common format for PRRSV antibody detection and commercial PRRSV
antibody ELISA kits are widely available for serum and swine oral ﬂuid
specimens (Pejsak et al., 2017).
The ontogeny of PRRSV antibody in serum and oral ﬂuids has been
described using isotype-speciﬁc ELISAs. Kittawornrat et al. (2013),
using paired samples collected over time post inoculation, showed that
the temporal appearance of antibody isotypes in serum and oral ﬂuid
was essentially identical in animals inoculated with viable, replicating
PRRSV. That is, IgM was detectable by 7 days post inoculation (DPI),
IgA after 7 DPI, and IgG by 9 to 10 DPI. Because of the higher con-
centration of IgG relative to other isotypes, commercial ELISA kits
usually target the detection of IgG, although detection of IgM and IgA
has been used in human diagnostic medicine.
In addition to antibody produced in response to PRRSV infection or
vaccination, younger animals may also have ELISA-detectable PRRSV-
speciﬁc passive antibody, primarily IgG, in serum and oral ﬂuid
(Biernacka et al., 2016; Goyal, 1993; Ramirez et al., 2011). In oral ﬂuid-
based testing, maternally-derived antibody creates a challenge in dis-
cerning whether a positive ELISA is the result of infection, vaccination,
or maternal antibody. Therefore, the goal of this study was to develop a
PRRSV combined IgM-IgA oral ﬂuid ELISA and evaluate its perfor-
mance under experimental and ﬁeld conditions.
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2. Materials and methods
2.1. Experimental design
Two longitudinal studies were conducted to evaluate PRRSV oral
ﬂuid antibody ontogeny using isotype-speciﬁc ELISAs (IgM, IgA, IgG,
IgM-IgA). In Study 1 (experimental data), oral ﬂuid antibody isotype
responses were evaluated in individual pigs following administration of
a modiﬁed-live PRRSV vaccine. In Study 2 (ﬁeld data), PRRSV antibody
isotype responses were monitored in oral ﬂuid samples collected from
PRRS unvaccinated, group-housed pigs in commercial wean-to-ﬁnish
farms in Iowa USA. In Study 2, wild-type PRRSV infection was de-
termined by PRRSV real-time reverse-transcriptase PCR (RT-rtPCR)
testing and sequencing. Studies were conducted with the authorization
of the Iowa State University Oﬃce for Responsible Research and the
permission of the producers.
2.2. Animals and animal care and PRRSV status
Study 1 was an experimental study conducted in a biosafety level 2
research facility located at Iowa State University and accredited by the
Association for Assessment and Accreditation of Laboratory Animal
Care (AAALAC). The facility was designed with a single-pass, non-re-
circulating ventilation system, i.e., unidirectional ﬂow from low con-
tamination areas to high contamination areas. Each room was venti-
lated separately and humidity and temperature was strictly controlled.
Zones of negative pressure prevented airborne contamination from
area-to-area or room-to-room. Pigs were housed in individual pens
(1.52 m× 1.83 m) in one room.
Partitions with evenly-spaced vertical bars allowed interactions
between pigs in adjacent pens. Animal care, housing, and feeding were
under the supervision of the research facility staﬀ.
Pigs (n = 12; 50 kg) were sourced from a PRRSV-naïve commercial
herd. To conﬁrm PRRSV-naïve status, pigs were tested for PRRSV serum
antibody at 19 and 11 days prior to arrival at the research facility and
again prior to vaccination. Pigs were acclimated in the facilities for
5 days and then vaccinated with a modiﬁed-live PRRS vaccine on Day 0
of the study (Ingelvac PRRS® MLV, Boehringer Ingelheim Vetmedica
Inc., St. Joseph Missouri). Individual oral ﬂuid samples were collected
twice daily from each of the 12 pigs from Day−7 through Day 42 using
a protocol described elsewhere (Prickett et al., 2008a,b). In brief, one
100% cotton rope was hung in each pen for 30 min, during which time
the pigs interacted (chewed on) the rope. Thereafter, the wet portion of
the rope was inserted into a plastic bag and severed from the remainder
of the rope. Oral ﬂuid was extracted by passing the wet rope, still within
the bag, through a portable towel wringer (Dynajet, Nürtingen, Ger-
many). Samples were decanted into 50 mL centrifuge tubes and placed
on crushed ice. The morning and afternoon oral ﬂuid samples from each
day were combined, aliquoted into 5 mL cryovial tubes and stored at
−80 °C.
Study 2 was a ﬁeld study conducted on three separate farms in one
production system. Each farm (A, B, C) consisted of three curtain-sided,
wean-to-ﬁnish barns (1, 2, 3) sited parallel to each other and spaced
10 m apart. Barns (13.4 m × 61.0 m) were designed with split-zone
ventilation, independent control of curtains, and ridge ventilation by
zone. Manure was collected in shallow pits beneath each barn and
moved to an outdoor above-ground slurry storage tank via a scraper
system. All farms were managed on an all-in-all-out basis, with build-
ings cleaned and disinfected between groups. Animal housing, hand-
ling, feeding, and health care were implemented by producers and with
the assistance of production system veterinarians. For the purpose of
implementing this study, producers and veterinarians did not vaccinate
or move pigs between pens or barns during the 2-month sampling
period.
Each barn contained 40 pens arranged as 20 pens on either side of a
central walkway. On Farm A, pens (3 m × 6 m) were built with solid
concrete walls and partial slats. On Farm B and C, pens (3 m × 6 m)
were built with gated walls and partial slats. During the collection
period, all occupied pens held ∼25 pigs. Barns were populated with
weaned pigs (∼21 days of age) sourced from one PRRSV-endemic
breeding herd over the course of 7 to 14 days, but each farm's pigs came
from a diﬀerent sow herd. For all breeding herds, commercial modiﬁed-
live PRRS vaccines were administered to replacement gilts during
quarantine, but not to sows or pigs in other phases of production.
Oral ﬂuid samples were collected weekly from every occupied pen
(n = 36) in every barn (n = 3) on each farm (n = 3) using the proce-
dure described above. Samples were decanted into 50 mL centrifuge
tubes and placed on crushed ice for transport to the laboratory. Samples
were aliquoted into 4 mL cryovials in the laboratory and stored at
−20 °C.
After weekly oral ﬂuid collection, blood samples were collected
from 20 pigs in each barn by sampling 10 pigs from each of two pens.
Pens selected were approximately 1/4 of the distance from each end of
the barn on opposite sides of the walkway. The same pens were sampled
each week, but not necessarily the same pigs (convenience sampling).
Blood samples were collected using a single-use vacutainer system with
10 mL serum separation tubes (Becton, Dickinson and Company,
Franklin Lakes, NJ, USA). Blood samples were placed on ice for trans-
port to the laboratory. In the laboratory, samples were centrifuged
(1000g for 10 min), aliquoted into 4 mL cryovials, and stored at
−20 °C.
2.3. PRRSV ELISAs
Serum samples were tested for PRRSV antibodies using a commer-
cial PRRSV ELISA (IDEXX PRRS ×3 Ab Test, IDEXX Laboratories, Inc.,
Westbrook ME USA) following the instructions provided by the manu-
facturer. Sample-to-positive (S/P) results ≥0.4 were considered posi-
tive for PRRSV antibody.
Oral ﬂuid samples were tested for PRRSV antibodies using a com-
mercial PRRSV oral ﬂuid antibody (IgG) ELISA (IDEXX PRRS OF Ab
Test, IDEXX Laboratories, Inc.) following the instructions provided by
the manufacturer. S/P results≥0.4 were considered positive for PRRSV
antibody. IgM, IgA, and IgM-IgA oral ﬂuid ELISAs were performed as
instructed by the manufacturer for the PRRSV OF Ab ELISA (IgG) with
the following exceptions: the kit IgG conjugate was replaced with goat
anti-pig IgM (A100-100P Bethyl Laboratories) diluted 1/5000 in IDEXX
conjugate diluent; or goat anti-pig IgA (A100-102P Bethyl Laboratories)
diluted 1/3000 in IDEXX conjugate diluent; or dual mixture of IgM (1/
5000)-IgA (1/3000). Plate positive controls for the IgM, IgA, or IgM-IgA
ELISAs were based on oral ﬂuid samples of known positive PRRSV
status diluted in kit sample diluent to produce optical density (OD)
values between of 0.6 and 0.7. Tests were performed as recommended
by the manufacturer and results reported as S/P ratios. Cutoﬀs for the
IgM, IgA, and IgM-IgA oral ﬂuid ELISAs were determined by receiver
operator characteristic curve (ROC) analysis, as described in Section 2.6
(statistical analysis).
2.4. PRRSV RT-rtPCR
All samples were tested for PRRSV RNA at the Iowa State University
Veterinary Diagnostic Laboratory (ISU VDL) using standard protocols.
Systematic bias was addressed by randomizing samples order prior to
submission.
In Study 2 (ﬁeld data), serum samples from the same pen were
pooled by ﬁve and tested by PRRSV RT-rtPCR. Nucleic acid extraction
was performed using the MagMAX™ viral RNA isolation kit (Life
Technologies, Carlsbad, CA, USA) and a Kingﬁsher 96 magnetic particle
processor (Thermo-Fisher Scientiﬁc, Waltham, MA, USA) using a stan-
dard lysis procedure. A lysis/binding solution was prepared with 65 μL
lysis/binding solution, 1 μL carrier RNA, 65 μL isopropanol and 2 μL
Xeno™ RNA template at 10,000 copies/μL. At the lysis step, 130 μL of
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the prepared lysis/binding solution was added to 20 μL of magnetic
bead mix prior to extraction and elution into 90 μL buﬀer. The standard
lysis procedure used 150 μL in wash I and 150 μL in wash II. The ex-
traction was performed using the Kingﬁsher AM1836_DW_50_v3 pro-
gram (Thermo-Fisher Scientiﬁc).
In Study 2, oral ﬂuid samples were tested individually (not pooled)
for PRRSV RT-rtPCR testing. Nucleic acid extraction was performed
using the MagMAX™ viral RNA isolation kit and a Kingﬁsher 96 mag-
netic particle processor using a high-volume modiﬁed lysis (HVML)
procedure. A modiﬁed lysis/binding solution was prepared with 120 μL
lysis/binding solution, 2 μL carrier RNA, 120 μL isopropanol and 2 μL
Xeno™ RNA template at 10,000 copies/μL. At the lysis step, 240 μL of
the prepared lysis/binding solution was added to 20 μL of magnetic
bead mix prior to extraction and elution into 90 μL elution buﬀer. An
additional modiﬁcation for the HVML procedure was an increase in
wash I and II solutions, i.e., the procedure used 300 μL in wash I and
450 μL in wash II. The extraction was performed using the Kingﬁsher
AM1836_DW_HV_v3 program.
Both serum and oral ﬂuid samples were assayed using a commercial
PRRSV real-time RT-rtPCR kit (EZ-PRRSV MPX 4.0 assay, Tetracore©,
Rockville, MD, USA). For each run, positive controls for PRRSV Types 1
and 2 and a negative ampliﬁcation control were included. For each
control well, 17.25 μL of EZ-PRRSV MPX 4.0 Reagent was added. The
EZ-PRRSV MPX 4.0 Reagent includes buﬀer, primer and probes, 0.75 μL
Enzyme Blend, 0.25 μL IC and 7 μL of positive control (Type I or 2 IVT)
or negative control (1× TE). Each well contained 17.25 μL of the EZ-
PRRS MPX 4.0 Reagent, which included buﬀer, primer, probes, 0.75 μL
Enzyme Blend and 7 μL of the oral ﬂuid extract. Plates were loaded onto
the thermal cycler (7500 Fast Real-Time PCR System, Applied
Biosystems©, Foster City, CA, USA) and the following cycling condi-
tions were used: one cycle at 48 °C for 15 min, one cycle at 95 °C for
2 min, 45 cycles of: 95 °C for 5 s, and 60 °C for 40 s. Samples with Ct
values< 45 for Type 2 PRRSV were considered positive.
2.5. PRRSV sequencing
In Study 2 (ﬁeld data), one RT-rtPCR-positive pooled serum sample
(pool of 5) from each barn was selected for PRRSV sequencing each
week. Approximately 1082 base pairs of open reading frame (ORF)5
region and the ﬂanking regions within the PRRSV genome were am-
pliﬁed using forward primer 5′-AAG GTG GTA TTT GGC AAT GTG
TC-3′ and reverse primer 5′-GAG GTG ATG AAT TTC CAG GTT TCT A-3′
and the qScript™ Custom One-Step RT-rtPCR Kit (Quanta Biosciences,
Gaithersburg, MD USA). The serum sequencing PCR setup reaction used
320 nM of each primer with 12.5 μL 2X qScript™ One-Step master mix,
0.5 μL qScript One-Step reverse transcriptase and 7.2 μL nuclease-free
water. The ﬁnal PCR volume of 25 μL consisted of 21 μL of master mix
and 4 μL of RNA extract. One positive extraction control, one negative
extraction control, and one negative ampliﬁcation control were in-
cluded with the reaction. The PCR was performed (Applied Biosystems®
2720 thermal cycler, Life Technologies Corporation) with the following
cycling conditions: one cycle at 48 °C for 20 min, one cycle at 94 °C for
3 min, 45 cycles of 94 °C for 30 s, 50 °C for 50 s, and 68 °C for 50 s. The
ﬁnal elongation step was 68 °C for 7 min. Detection of the RT-rtPCR
product of the correct size (1082 bp) was performed on a QIAxcel®
capillary electrophoresis system (Qiagen®) using a DNA screening car-
tridge and the AM420 method and puriﬁed with ExoSAP-IT®
(Aﬀymetrix, Santa Clara, CA USA) following the manufacturer’s re-
commendations. Samples were submitted to the Iowa State University
DNA Facility for sequencing and commercial software was used to
compile sequences (Lasergene®, DNAStar, Madison, WI, USA).
2.6. Statistical analysis
Receiver operating characteristic curve (ROC) analyses were per-
formed in R 3.3.0 (R Core Team, 2013) with the objective of calculating
the cutoﬀs and associated diagnostic sensitivity and speciﬁcity for each
oral ﬂuid antibody isotype-speciﬁc ELISA assay. PRRSV IgM, IgA, and
IgM-IgA ELISA ROC analyses were done separately for Study 1 and
Study 2.
In Study 1 (experimental data), sample status (positive/negative)
was deﬁned relative to the day of vaccination (Day 0, Ingelvac PRRS®
MLV). For the PRRSV IgM and IgM-IgA ELISA ROC analyses, samples
from days−7 to 5 were considered negative and samples from days 10
to 28 as positive. For the PRRSV IgA and IgG ELISA ROC analyses, days
−7 to 7 were classiﬁed as negative and days 11 to 28 as positive.
In Study 2 (ﬁeld data), the infection status for pen-based samples
was determined by RT-rtPCR testing. For the ROC analyses, oral ﬂuid
samples from a pen were considered IgM and IgA antibody negative up
to, and including, the ﬁrst positive PRRSV RT-rtPCR result from the
pen. Thereafter, samples were considered positive for IgM beginning
with the next weekly sampling and for four subsequent weekly sam-
plings. For IgA and IgM-IgA ELISA ROC analyses, samples were con-
sidered positive for all weekly samplings after the ﬁrst RT-rtPCR posi-
tive result. The IgG ELISA results were not analyzed due to the presence
of maternal PRRSV antibody.
For both Study 1 and 2, transformation of S/P values (x3/7) was
performed to fulﬁll the assumption of normality for the IgM, IgA, and
IgM-IgA data. Thereafter, a linear mixed model was ﬁtted to the data,
with PRRSV infection status as the explanatory variable and pen as the
random eﬀect. After obtaining the ﬁxed parameter estimates and
standard deviation, point estimates, variance, and conﬁdence intervals
for diagnostic sensitivity and speciﬁcity were calculated based on the
Normal model. Because of the correlated structure of the data, i.e.,
repeated measures at the sampling level, binomial exact conﬁdence
intervals were calculated using model-based estimation of diagnostic
sensitivity and speciﬁcity. Asymptotic logit transformation was used to
avoid conﬁdence intervals beyond [0, 1]. That is, diagnostic sensitivity
and speciﬁcity point estimates were ﬁrst logit transformed, then con-
ﬁdence intervals were calculated, after which the ﬁnal conﬁdence in-
tervals were obtained by back transformation.
3. Results
All samples were randomized prior to PRRSV ELISA or RT-rtPCR
testing. All samples were tested once and no retests were performed.
3.1. Study 1 (experimental data)
Study 1 followed the PRRSV oral ﬂuid antibody isotype response of
12 pigs following vaccination with a modiﬁed-live PRRSV vaccine
(Ingelvac PRRS® MLV, Boehringer Ingelheim Vetmedica, Inc.) under
experimental conditions. All pigs were conﬁrmed free of PRRSV infec-
tion by PRRSV RT-rtPCR and PRRSV ELISA testing. From DPV −7 to
42, oral ﬂuid samples were collected twice daily from individual pigs
for a total of 600 oral ﬂuid samples. At the end of the trial, all samples
were tested for PRRSV antibody using isotype-speciﬁc ELISAs (IgM,
IgA, IgG, and IgM-IgA). The oral ﬂuid isotype-speciﬁc ELISA mean S/P
values and the percent of IgM-IgA ELISA samples with S/P ratios≥0.40
by DPV are shown in Fig. 1.
3.2. Study 2 (ﬁeld data)
Study 2 was conducted on 3 commercial farms (A, B, C) in one
production system, each with 3 wean-to-ﬁnish barns (1, 2, 3). Oral ﬂuid
samples were collected weekly from the 36 occupied pens (∼25 pigs
per pen) in each of the 3 barns, i.e., 108 samples per week, for a total of
∼972 oral ﬂuid samples per farm. In addition, 20 serum samples from
two pens in each barn were collected at each weekly sampling for a
total of 1620 serum samples per farm. The PRRSV status of barns and
farms was determined on the basis of RT-rtPCR testing and reﬂected the
endemic circulation of virus in the production system. No PRRSV
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vaccine was used in the pigs or their dams during the production cycle.
The PRRSV RT-rtPCR results for oral ﬂuid samples are shown in
Fig. 2. In Farm A, PRRSV RT-rtPCR-positive oral ﬂuid samples were
observed in one or more of the three barns at every sampling period
(week 0 through 8). Of the 972 oral ﬂuid samples collected on Farm A,
425 samples were positive. At the last sampling, all oral ﬂuid samples
collected from all Farm A (n = 108) were positive. No RT-rtPCR-posi-
tive oral ﬂuid samples were observed in Farm B and in Farm C one oral
ﬂuid sample tested positive at week 8.
PRRSV RT-rtPCR-positive serum samples (pooled by ﬁves) were
found in Farm A on sampling weeks 4 through 8. No RT-rtPCR-positive
serum samples were detected at any time in Farms B and C. In Farm A,
PRRSV sequencing was attempted on RT-rtPCR-positive pooled serum
samples collected weeks 4 through 8. To optimize sequencing success
and collect sequencing data over time, the pool with lowest Ct was
selected each week from each barn. A total of 14 pooled serum samples
were submitted for sequencing and 10 ORF 5 sequences were obtained.
Sequence analysis provided evidence of the circulation of wild-type
PRRSV (Fig. 3).
All oral ﬂuid samples collected in Study 2 (n = 2916) were tested
for PRRSV antibody using isotype-speciﬁc ELISAs (IgM, IgA, IgG and
IgM-IgA). The mean S/P values for the IgG ELISA and IgM-IgA ELISA
are shown in Fig. 4. The percent of IgM-IgA ELISA samples with S/P
ratios ≥0.40 by sampling week are given in Fig. 2.
3.3. ROC analysis
For both Study 1 (experimental data from individual pigs) and
Study 2 (ﬁeld data from pens of pigs), the diagnostic sensitivities,
speciﬁcities, and 95% correlated conﬁdence intervals were calculated
for the IgA, IgM, and IgM-IgA ELISAs over a range of S/P cutoﬀs of 0.20,
0.30, 0.40, 0.50, and 0.60 (Table 1). For Study 1, the oral ﬂuid isotype-
speciﬁc ELISA mean S/P values and the percent of IgM-IgA ELISA
samples with S/P ratios≥0.40 by DPV are shown in Fig. 1. Two of 156
samples collected between DPV -7 to 5 had S/P values ≥0.40. Speci-
ﬁcally, one sample collected on DPV -3 had an S/P value of 0.46 and
one sample collected on DPV -1 had an S/P value of 0.53. These values
were accounted for in the ROC analysis (Table 1), resulting in a diag-
nostic speciﬁcity of 99%.
4. Discussion
Various economic studies have uniformly shown that PRRSV inﬂicts
major losses on swine health and productivity (Holtkamp et al., 2013;
Nathues et al., 2017; Neumann et al., 2005; Nieuwenhuis et al., 2012;
Zhang and Kono, 2012). In Europe and North America, the cost of
PRRSV to the industry in terms of hog marketed has been estimated at
$6.25 to $15.25 per pig (Holtkamp et al., 2013; Nathues et al., 2017).
On-going losses at this level are unacceptable in terms of animal welfare
and the public's perception of swine production, but the solution to this
dilemma is not apparent. Calvin Schwabe in 1982 recommended that
veterinary practitioners use surveillance to understand the patterns of
disease and establish baselines against which the eﬀect of control in-
terventions could be measured. Schwabe's vision was never realized,
but the complex, dynamic, global nature of contemporary swine pro-
duction mandates that on-going, near-real-time surveillance be part of
the PRRSV solution.
PRRSV surveillance can be based on the detection of nucleic acid
and/or antibody: each has its strengths and weaknesses. The time to RT-
rtPCR-detectable viremia diﬀers among PRRSV isolates, but the ma-
jority of animals are viremic within 48 h (Pepin et al., 2015). Under
experimental conditions, ∼50% of pigs were still nucleic acid-positive
at ∼50 DPI and ≤10% of animals remained positive at ∼100 DPI
(Horter et al., 2002; Molina et al., 2008). This unusually long duration
of viremia makes nucleic acid detection a viable option for PRRSV
surveillance. However, serum-RT-rtPCR-negative animals can still
harbor infectious PRRSV. That is, after the immune response clears
virus from the circulatory system, infectious PRRSV can still be re-
covered from lymphoid tissues, e.g., tonsils of the soft palate (Horter
et al., 2002; Wills et al., 2003).
The humoral immune response against a variety of PRRSV proteins
has been described (Molina et al., 2008) and a variety of serum anti-
body detection platforms are available in diagnostic laboratories, e.g.,
ELISA, IFA, IPMA and neutralizing antibody assays (Decorte et al.,
2014; Ouyang et al., 2013; Pejsak et al., 2017; Yoon et al., 1995). ELISA
is compatible with high-throughput laboratories, is technically simple,
and is a widely used assay for PRRSV antibody detection (Pejsak et al.,
2017). Kittawornrat et al. (2012a, 2012b) in a study involving 12 la-
boratories found that the results produced by a PRRSV oral ﬂuid ELISA
were highly repeatable within laboratories and highly reproducible
between laboratories. When used in surveillance, PRRSV serum and
oral ﬂuid ELISAs can provide useful data concerning herd immunity
Fig. 1. PRRSV antibody ontogeny in oral ﬂuid samples collected from
12 pigs vaccinated with a modiﬁed-live virus vaccine over the course
of 49 days (Study 1).
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and exposure history. However, PRRSV maternal antibody may be
present in pigs up to 10 weeks old (Yoon et al., 1996; Houben et al.,
1995). The presence of maternal IgG antibody complicates the inter-
pretation of ELISA results because, in younger pigs, a positive result
may represent maternal antibody or antibody produced by the pig in
response to PRRSV infection.
Prior research demonstrated that inoculation with type 1, type 2, or
MLV PRRS viruses produced detectable levels of PRRSV IgM and IgA in
Fig. 2. Oral ﬂuid testing results (% positive) in PRRSV-posi-
tive (A) and PRRSV-negative (B, C) wean-to-ﬁnish farms
(Study 2).
0246
Barn 2, week 7
Barn 2, week 6
Barn 2, week 8
Barn 3, week 7
Barn 3, week 8
Barn 1, week 5
Barn 1, week 7
Barn 1, week 6
Barn 1, week 8
MLV derived from VR-
VR-2332
Fig. 3. Phylogenetic analysis (ORF 5 nucleotide level) of
wild-type PRRS viruses circulating in Farm A (Study 2).
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both serum and oral ﬂuid (Kittawornrat et al., 2013). The goals of the
present research were to develop a combined IgM-IgA oral ﬂuid ELISA,
evaluate its performance using experimental and ﬁeld samples, and
determine whether the assay could detect PRRSV-speciﬁc IgM and IgA
produced by pigs in response to infection, even in the presence of
maternal IgG antibody.
Using samples from MLV-vaccinated pigs and type 2 ﬁeld virus-in-
fected pigs, the results conﬁrmed prior reports of IgM, IgA, and IgG
antibody ontogeny in oral ﬂuids following exposure to the virus.
Testing of oral ﬂuids from pigs originating from sow herds endemically
infected with PRRSV found abundant PRRSV IgG, but no evidence of
maternally-derived IgM or IgA in oral ﬂuid specimens.
A comparison of IgM, IgA, and IgM-IgA ELISAs showed that the
combined IgM-IgA assay provided better performance than detection of
either isotype alone (Table 1). The authors were unable to locate other
examples of combined antibody isotype ELISAs with which to compare
these data, but there are examples of combining the results of two
diﬀerent isotype assays to establish infection status. For both Dengue
virus and Crimean-Congo hemorrhagic fever virus, performing IgM and
IgG ELISAs in parallel and interpreting a positive result on either as
indicative of infection signiﬁcantly improved diagnostic sensitivity
(Dowall et al., 2011; Vaughn et al., 1999). While the combined IgM-IgA
oral ﬂuid ELISA demonstrated adequate diagnostic sensitivity and high
diagnostic speciﬁcity, higher performance may be achievable through
further assay optimization and/or the removal of IgG. Removal of IgG
from specimens using anti-IgG or protein G has been described as a
method to improve detection of IgM and IgA (Ankerst et al., 1974;
Martins et al., 1995). For example, Dowall et al. (2011) showed that
removal of IgG from diagnostic samples resulted in increased both the
diagnostic sensitivity and speciﬁcity of a Crimean-Congo hemorrhagic
fever virus IgM ELISA.
Overall, the combined PRRSV IgM-IgA oral ﬂuid ELISA described in
this proof-of-concept study is a promising tool for PRRSV surveillance,
particularly in populations of growing pigs originating from PRRSV-
Fig. 4. Oral ﬂuid testing results (mean S/P) in PRRSV-posi-
tive (A) and PRRSV-negative (B, C) wean-to-ﬁnish farms
(Study 2).
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positive or vaccinated breeding herds because of its ability to detect
pig-derived IgM and IgA antibody in the presence of maternal IgG.
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